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Background:  There  is  a growing  need  to  understand  trends  in  nonmedical  use  of prescription  pain  relievers
as a  class,  as  well  as  speciﬁc  opioid  products.  Surveys  such  as  monitoring  the  future  (MTF)  and  the
National  Survey  on  Drug  Use  and  Health  (NSDUH)  are  important  tools  for understanding  trends  in  abuse
of prescription  and  illegal  drugs.  This  report  compares  discrepancies  in prevalence  between  these  surveys
for  a speciﬁc  opioid  product  (oxycodone)  relative  to  other  drugs.
Methods:  Trends  in  past-year  use  of marijuana,  cocaine,  and  nonmedical  use  of  oxycodone  and  any  pre-
scription  pain  reliever  were  estimated  for  each  survey  for a ﬁve  year  period  (2005–2010)  for  adolescents
in 12th  grade.  The  proportion  of  nonmedical  pain  reliever  users  who  abused  oxycodone  was  estimated
for each  survey.
Results:  Prevalence  of  past-year  oxycodone  nonmedical  use  was  steady  over  time  for  both  surveys,  but
2.5–3  times  higher  in  the  MTF compared  to  the  NSDUH.  Trends  in  prevalence  of marijuana  and  cocaine
use  were  similar  across  surveys,  although  prevalence  estimates  for  each  were  on  average  18% higher
in  the  MTF.  In contrast,  prevalence  estimates  for  any  nonmedical  prescription  pain  reliever  use were
on average  15%  lower  in  MTF.  The  proportion  of  nonmedical  prescription  pain  reliever  users  who  used
oxycodone  was  42%  in  the  MTF  versus  19%  in  the  NSDUH.
Conclusion:  The  discrepancy  between  surveys  in prevalence  estimates  for nonmedical  use  of oxycodone
exceed  those  for  other  drugs,  pointing  to  the  importance  of  visual  aids  and  items  used to  measure  the
nonmedical  use  of  speciﬁc  products.
 The A .© 2013
. Introduction
The abuse of prescription pain relievers among adolescents
s an important public health problem. In order to appropriately
ddress this problem, it is essential to understand nonmedical use
nd related problems for these medications. Surveys, such as the
onitoring the Future (MTF) study and the National Survey on
rug Use and Health (NSDUH), are important tools for understand-
ng trends in prevalence of abuse of these drugs. In addition to
he need to measure prevalence of nonmedical use of prescription
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pain relievers as a class, there is a growing need for estimates of
prevalence of speciﬁc opioid products for a variety of reasons, such
as to test the impact of abuse deterrent opioid formulations or to
evaluate the impact of the Food and Drug Administration’s (FDA)
recently instituted class-wide Risk Evaluation and Mitigation
Strategy (REMS) for extended-release opioid products. Product
speciﬁc prevalence is being used more widely to inform policy.
For example, both NSDUH and MTF  were recently cited by the FDA
in the brieﬁng material for the Drug Safety and Risk Management
Advisory Committee meeting on scheduling of hydrocodone (Food
and Drug Administration, 2013a,b).
In order to ensure that ﬁndings from these surveys inform policy
and practice effectively through accurate measures of prevalence, it
is essential to maximize the validity of responses to questions about
the nonmedical use of any prescription pain reliever, as well as
Open access under CC BY-NC-SA licensefor speciﬁc opioid products. Measurements of self-reported health
risk behaviors, such as drug use, vary by setting, mode of admin-
istration, and question wording. Prevalence estimates are typically
higher in surveys administered at school versus home, higher for
-NC-SA license.
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omputer-assisted self-interview than paper and pencil adminis-
ration, and variable due to question clarity and speciﬁcity (Brener
t al., 2006, 2004; Turner et al., 1998).
A report produced by the Substance Abuse and Mental Health
ervices Administration (SAMHSA) compared prevalence estimates
or abuse of alcohol, cigarettes, marijuana, cocaine, ecstasy, non-
edical prescription pain relievers, LSD, and inhalants estimated
n the NSDUH and MTF  surveys for adolescents age 12–17 years
ld (SAMHSA, 2011). The report found that past month prevalence
f alcohol, cigarette, and marijuana use were higher in the MTF
8th and 10th grade reports combined) as compared to 12–17 year
lds assessed by the NSDUH. Similarly, past year nonmedical pain
eliever use reported was higher for 12th graders assessed in the
TF  report than in the NSDUH sample. Although the samples were
ot directly aligned by age, ﬁndings from this report point to dif-
erences in measurement of nonmedical use of prescription pain
elievers and illegal drugs, which could be due to survey method-
logy (setting, sample, method of administration, and question
tructure).
The current study aims to extend these ﬁndings focusing on a
omparison of prevalence estimates across these two  surveys for a
randed prescription opioid product, oxycodone, which has been
 focus of concern for abuse in adolescent and adult populations
Meier et al., 2012; Martins et al., 2009). Oxycodone serves as an
ccessible example because it is the only speciﬁc opioid product for
hich both surveysprovide estimates of past year prevalence, and
ndings based on this product are likely to be relevant to other spe-
iﬁc products. We  compared trends in the part year prevalence of
xycodone as well as overall nonmedical pain reliever, marijuana,
nd cocaine use as reported by 12th graders to assess whether the
agnitude and direction of differences in prevalence estimates for
xycodone were similar to those for other drugs.
Systematic differences in magnitude and direction of prevalence
stimates would reﬂect overall methodologic differences of the sur-
eys while a pattern of ﬁndings unique to a single product would
eﬂect error in measurement beyond systematic variation expected
ue to general survey methodology.
. Methods
Trends in drug use prevalence among 12th grade subjects were compared using
wo  surveys, NSDUH and MTF, spanning years 2005–2010. While the primary focus
f  this report is on the responses of 12th graders, the prevalence estimates of 8th
nd 10th graders were also compared. The NSDUH is conducted using a nationally
epresentative sample of households throughout the United States of those ages
2  years and older. The survey employs a combination of computer assisted self-
nterviewing (CASI) and interviewer administered prompts (SAMHSA, 2011). The
TF  is a school-based survey that measures drug use and related behaviors among
th, 10th, and 12th graders in a sample of approximately 400 public and private
chools in the United States using pencil and paper questionnaire (Johnston et al.,
011). In this study we  focus on 12th graders in the MTF  as well as those reporting
hat they were in 12th grade at the time of survey in the NSDUH. In 2010, the MTF
urveyed 15,127 children in the 12th grade and the NSDUH surveyed 3020 children
n  the 12th grade. These relative estimates are consistent across survey years.
In  addition to differences in the nature of sample, survey setting, and method
f  survey administration, the surveys use different approaches for the assessment
f  prescription pain relievers, including oxycodone as shown in Fig. 1. Both surveys
rovide an introduction explaining the deﬁnition of prescription opioid pain reliev-
rs  and nonmedical use. However, the NSDUH employs a series of items to assess
onmedical use of various pain relievers and follows up with a series of questions,
ith  frequency queried in a separate item whereas MTF  uses only a single item that
nquires about frequency of use such that anything other than “never” is considered
se.
As shown in Fig. 1, NSDUH Items A through C each query about speciﬁc products
hat contain codeine, oxycodone, and hydrocodone, respectively. Item D asks about
onmedical use of the remaining eighteen products shown on the pill card. If Item D
s  answered in the afﬁrmative, the respondent is asked to specify which product(s)
ere used. Respondents are then queried about nonmedical use of pain relievers not
hown on the pill card. Respondents who report nonmedical use of any opioid pain
eliever then are asked a series of questions about age of ﬁrst use, use in past year,
ow recent and frequently use occurred in the past year for any opioid pain reliever.
f  respondents report any lifetime nonmedical use of oxycodone in response to Iteml Dependence 134 (2014) 396– 400 397
D they are asked the same series of follow-up questions speciﬁcally for oxycodone.
oxycodone is the only speciﬁc pain reliever queried with these additional items.
The MTF  survey instrument uses the term narcotics in place of pain reliever. It
introduces the narcotics section by explaining that some narcotics are prescribed
by doctors. The respondent is then asked on how many occasions they have taken
narcotics other than heroin in the last 12 months. Nonmedical use of oxycodone is
assessed using a single item that asks on how many occasions the respondent has
taken oxycodone without doctor’s orders. MTF  does not use a pill card.
Trends in prevalence of past-year use of oxycodone, marijuana, cocaine, and
any  prescription pain reliever were estimated for each survey for a ﬁve year period
(2005–2010) using survey weights. The proportion of oxycodone users among non-
medical pain reliever users in the MTF  and NSDUH datasets were compared to
characterize the extent to which a speciﬁc product (oxycodone) accounted for preva-
lence of nonmedical prescription pain reliever use.
3. Results
As shown in Fig. 2, both surveys indicate stable trends in preva-
lence of nonmedical oxycodone use from 2005 to 2010 (Fig. 2A).
However, the past-year prevalence of oxycodone was 2.5–3 times
higher in the MTF  than in the NSDUH; ranging from 4.3% to 5.5% in
the MTF  versus 1.4–2.1% in the NSDUH. In contrast, relative differ-
ences in prevalence estimates between the two  surveys were much
smaller for other drugs examined. Annual prevalence estimates of
use of illegal drugs (marijuana and cocaine) were greater accord-
ing to MTF  than NSDUH (Fig. 2C and D). Trends in the prevalence of
marijuana and cocaine use were similar in both surveys, in which
prevalence of marijuana use was steady and cocaine use declined
from 2005 to 2010. However, prevalence estimates were each on
average 18% higher for MTF  than for NSDUH. In contrast, prevalence
for use of prescription pain reliever was  on average 15% lower in
MTF  as compared to NSDUH (Fig. 2B). The MTF  reports prevalence
steady around 8% for 2005 through 2010 while NSDUH ranged from
10% to 12%.
The percentage of nonmedical prescription opioid users who
were oxycodone users was  more than twice as high based on the
MTF  compared to the NSDUH. On average, in the MTF  thprevalence
of oxycodone use among past year nonmedical prescription opioid
users was  42% versus 19% for NSDUH. Analysis of 8th, 10th, and 12th
grade respondents showed similar trends for vicodin/hydrocodone
use (two other speciﬁc products queried in both surveys although
only for lifetime use) in which the MTF  yielded higher prevalence
estimates than the NSDUH.
The analysis of 8th and 10th graders yielded similar ﬁndings:
past year oxycodone prevalence was  three times higher in MTF  than
in NSDUH. The reported use of other drugs was more consistent
between NSDUH and MTF  across all age categories as compared to
the reported use of oxycodone.
4. Discussion
In contrast to the incremental difference in prevalence esti-
mates observed between NSDUH and MTF  for illegal drugs and
nonmedical use of any prescription pain reliever, there was  nearly
a three-fold difference between the two  surveys for prevalence of
nonmedical use of oxycodone. The differences in prevalence esti-
mates for oxycodone compared to those for other drugs extend
beyond the effects of setting and mode of survey administration.
The observed pattern for prescription opioids in which the MTF
yielded considerably higher prevalence estimates than the NSDUH
for oxycodone but lower estimates for prescription opioids over-
all is likely due to differences in the approach used in the survey
instruments to assess use of these drugs. In addition to differences
in prevalence, the ﬁnding that oxycodone accounts for a much
higher proportion of nonmedical opioid users in the MTF  than in
the NSDUH indicates that the different measurement approaches
can lead to different inferences.
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Fig. 1. NSDUH and MTF items assessing nonmedical prescription pain reliever use.
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iig. 2. Trends in past year prevalence of selected drugs among 12th graders in the 2
MTF) study.
The NSDUH uses pillcards with pictures of speciﬁc pain relievers,
hich may  increase the speciﬁcity of measurement of oxycodone
hile also increasing the sensitivity of opioids in general relative
o the single item with no pillcard in the MTF  instrument. With-
ut a visual aid depicting oxycodone and other prescription pain
elievers, it is possible that respondents in the MTF  are less likely
han those in the NSDUH to differentiate between different types
f oxycodone and other opioid medications, as well as differenti-
ting among various oxycodone products. The NSDUH, however,
oes not ask about oxycodone unless the respondent identiﬁes it
s a drug they have used nonmedically on the pillcard while MTF
ffers oxycodone as a speciﬁc answer choice. To the extent to which
espondents do not notice pictures or the label of oxycodone on the
illcard, there could be under-reporting. The higher prevalence of
ny prescription pain reliever observed in the NSDUH could be due
n part to multiple prompts in the NSDUH including pictures of
1 types of medications on the pillcard as well as a series of items
uerying about 3 speciﬁc groups of opioids displayed on the pillcard
Darvon/Darvocet/Tylenol with codeine, oxycodone combination
roducts, hydrocodone combination products) and an additional
tem querying about the remaining 18 groups of pain relievers on
he pillcard. It is possible that this approach increases sensitivity of
esponses regarding the nonmedical use of any prescription pain
eliever in the NSDUH relative to the MTF, although there is no
old standard to determine which set of prevalence estimates are
ore valid.
Public health strategy and policy is best informed by accurate
easures of health behaviors. Given the public health signiﬁcance
f abuse of prescription opioids and a growing need to measure
he nonmedical use of speciﬁc opioid products for reasons such as
EMS evaluation and assessment of abuse deterrent formulations
FDA, 2013), it is especially important that major national surveys
hat are widely used to inform policy and practice use measures that
aximize the validity of responses about these behaviors. Find-
ngs from this report point to the impact of question structure and2010 National Survey on Drug Use and Health (NSDUH) and Monitoring the Future
wording beyond general survey methodology and suggest that the
impact of visual aids should be well understood, especially when
measuring prevalence of speciﬁc opioid products.
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